Hsi-Ming Lee Selected Research

Tetracycline (Achromycin)

05/2006	Chemically modified tetracycline improves contractility in porcine coronary ischemia/reperfusion injury.
10/2005	Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model.

2	Periodontitis 08/2008 - 03/2004
1	Alveolar Bone Loss 09/2007
1	Reperfusion Injury 05/2006
1	Inflammation 01/2006
1	Septic Shock (Toxic Shock Syndrome) 10/2005
1	Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2005
1	Breast Neoplasms (Breast Cancer) 01/2005
1	Acute Coronary Syndrome 04/2004

3	Doxycycline (Vibramycin)FDA LinkGeneric 09/2007 - 03/2004
2	Tetracycline (Achromycin)FDA LinkGeneric 05/2006 - 10/2005
1	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 08/2008
1	Matrix MetalloproteinasesIBA 01/2006
1	TetracyclinesIBA 01/2005